Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2741399 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL19329252 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL8661259 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11337797 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11322829 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11909573 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL14244897 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11326465 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL20547697 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL28520079 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956382-B | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-113956477-B | Curing composition and application thereof, and cured polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-114031707-B | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-114031707-A | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113956477-A | Curing composition and application thereof, curing polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113956382-A | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2025-02-06 | — | — | US | disclosed |
| CN-113956382-B | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-113956477-B | Curing composition and application thereof, and cured polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-114031707-B | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023088919-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2023-05-25 | — | — | WO | disclosed |
| CN-108156812-B | Improved olefin metathesis catalysts | 卑尔根技术交易股份公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-07-14 | — | — | US | disclosed |
| WO-2012032131-A1 | NOVEL OLEFIN METATHESIS CATALYSTS | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2012-03-15 | — | — | WO | disclosed |
| EP-2428269-A1 | Novel olefin metathesis catalysts | Bergen Teknologioverføring AS (NO) | 2012-03-14 | — | — | EP | disclosed |
| US-6590048-B1 | Catalysts comprising group VIII compounds used for cyclization of crown ethers, antibiotics, veterinary medicines or perfumes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-07-08 | — | — | US | disclosed |
| EP-1037897-B1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1037897-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | Studiengesellschaft Kohle mbH (DE) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999028330-A1 | HIGHLY ACTIVE CATIONIC RUTHENIUM AND OSMIUM COMPLEXES FOR OLEFIN METATHESIS REACTIONS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1999-06-10 | — | — | WO | disclosed |
| EP-0921129-A1 | Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions | Studiengesellschaft Kohle mbH (DE) | 1999-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | SQLE, SYMPK, FDFT1 | ALDH1A1 1256/4885LMNA 3721/4885MAPT 2773/4885 |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | PPOX, CYBA, CYBB | ALDH1A1 1395/4885LMNA 4173/4885MAPT 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.